Literature DB >> 6345129

Metoclopramide. An updated review of its pharmacological properties and clinical use.

R A Harrington, C W Hamilton, R N Brogden, J A Linkewich, J A Romankiewicz, R C Heel.   

Abstract

Since previously reviewed in the Journal (Vol. 12, No. 2), metoclopramide has been confirmed as an effective drug in treating and preventing various types of vomiting and as a useful agent in oesophageal reflux disease, gastroparesis, dyspepsia, and in a variety of functional gastrointestinal disorders. Of considerable importance is the recent evidence of its efficacy when administered intravenously in high dosages in preventing severe vomiting associated with cisplatin. Good results have been achieved in patients not previously treated with cisplatin, but further studies are needed to determine its level of efficacy in patients who have experienced severe vomiting during earlier courses of cytotoxic therapy. Side effects consisting of mild sedation, diarrhoea and reversible extrapyramidal reactions have occurred, but are tolerated by many patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345129     DOI: 10.2165/00003495-198325050-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  194 in total

1.  Tardive dyskinesias.

Authors:  P Jenner; C D Marsden
Journal:  Lancet       Date:  1979-10-27       Impact factor: 79.321

2.  The influence of thiethylperazine on the absorption of effervescent aspirin in migraine.

Authors:  G Wainscott; T Kaspi; G N Volans
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

3.  A controlled trial of metoclopramide in symptomatic gastroesophageal reflux.

Authors:  R W McCallum; A F Ippoliti; C Cooney; R A Sturdevant
Journal:  N Engl J Med       Date:  1977-02-17       Impact factor: 91.245

4.  Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux.

Authors:  P Bright-Asare; M El-Bassoussi
Journal:  J Clin Gastroenterol       Date:  1980-06       Impact factor: 3.062

5.  Treatment of severe orthostatic hypotension by metoclopramide.

Authors:  O Kuchel; N T Buu; J Gutkowska; J Genest
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

6.  Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

Authors:  C Graffner; P O Lagerström; P Lundborg; O Rönn
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

7.  Metoclopramide. Management of gastrointestinal intolerance in rheumatoid arthritis patients.

Authors:  M S Awerbuch; S C Milazzo; R G Reiner; M H Alp
Journal:  Med J Aust       Date:  1981-05-02       Impact factor: 7.738

8.  Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide.

Authors:  J Behar; G Ramsby
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

9.  The effect of metoclopramide on the lower oesophageal sphincter in late pregnancy.

Authors:  J G Brock-Utne; T G Dow; S Welman; G E Dimopoulos; M G Moshal
Journal:  Anaesth Intensive Care       Date:  1978-02       Impact factor: 1.669

10.  Prevention of postoperative nausea and vomiting by domperidone: A double-blind randomized study using domperidone, metoclopramide and a placebo.

Authors:  R D Cooke; D J Comyn; R W Ball
Journal:  S Afr Med J       Date:  1979-11-17
View more
  61 in total

1.  Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.

Authors:  Yoshitaka Fujii
Journal:  Surg Endosc       Date:  2010-10-07       Impact factor: 4.584

Review 2.  Management of opioid-induced bowel dysfunction in cancer patients.

Authors:  Antonio Cesar Tamayo; Paola Andrea Diaz-Zuluaga
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

3.  Pharmacokinetics of metoclopramide in patients with liver cirrhosis.

Authors:  E Magueur; H Hagege; P Attali; E Singlas; J P Etienne; A M Taburet
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

4.  Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.

Authors:  F Albani; M R Tamè; R De Palma; M Bernardi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.

Authors:  A Hamik; S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 6.  Risks and benefits of drugs used in the management of postoperative nausea and vomiting.

Authors:  Y F Sung
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

Review 7.  The detoxification limitation hypothesis: where did it come from and where is it going?

Authors:  Karen J Marsh; Ian R Wallis; Rose L Andrew; William J Foley
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

8.  Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.

Authors:  P Sikiric; I Rotkvic; S Mise; M Petek; R Rucman; S Seiwerth; V Zjacic-Rotkvic; M Duvnjak; V Jagic; E Suchanek
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 9.  Pharmacology of antimigraine drugs.

Authors:  P R Saxena; M O Den Boer
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

10.  The effect of metoclopramide on mefloquine pharmacokinetics.

Authors:  K Na Bangchang; J Karbwang; D Bunnag; T Harinasuta; D J Back
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.